The Royal Marsden NHS Foundation Trust

Surrey SM2 5PT

1 studies enrolling now · 8 studies all time

What they study most

Advanced Multiple Myeloma, Chronic Lymphocytic Leukemia, Colorectal Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Metastatic Urothelial Cancer, Multiple Myeloma, Small Cell Lung Cancer, Triple Negative Breast Neoplasms

Studies at this site

• Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Recruiting now
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment — Completed
• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies — Completed
• A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) — Completed
• AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy — Completed
• A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations — Stopped early
• SPC2996 in Chronic Lymphocytic Leukaemia — Completed